Compounds > tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
Page last updated: 2024-09-03

tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Peripheral Nerve Diseases

tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Peripheral Nerve Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalso, E; Kontinen, VK; Panula, P; Xu, M1

Other Studies

1 other study(ies) available for tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Peripheral Nerve Diseases

ArticleYear
Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models.
    Peptides, 1999, Volume: 20, Issue:9

    Topics: Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Drug Antagonism; Injections, Spinal; Male; Motor Activity; Naloxone; Oligopeptides; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley

1999